Literature DB >> 30374551

[67/f with erythematous scaly plaques expanding centrifugally on the abdomen : Preparation for the specialist examination: part 11].

D Belz1.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30374551     DOI： 10.1007/s00105-018-4249-8

Source DB:  PubMed          Journal:  Hautarzt        ISSN： 0017-8470            Impact factor:   0.751


× No keyword cloud information.
  11 in total

Review 1.  [Cutaneous paraneoplastic syndromes].

Authors:  H Wolff
Journal:  Hautarzt       Date:  2001-02       Impact factor: 0.751

2.  [Erythema necroticans migrans in non-glucagon-secreting pancreas tumor].

Authors:  O Wilde; B Peters; T Doll; M Füchtenbusch
Journal:  Hautarzt       Date:  2007-12       Impact factor: 0.751

3.  [Erythema necrolyticum migrans after rectal adenocarcinoma].

Authors:  A Konstantinow; B R Balda; H Starz
Journal:  Hautarzt       Date:  1998-07       Impact factor: 0.751

4.  [Squamous epithelial carcinoma-associated necrolytic migratory erythema].

Authors:  M Möhrenschlager; L D Köhler; H Bruckbauer; A Walch; J Ring
Journal:  Hautarzt       Date:  1999-03       Impact factor: 0.751

5.  Treatment of malignant endocrine pancreatic tumors with a combination of alpha-interferon and somatostatin analogs.

Authors:  M L Fjällskog; A Sundin; J E Westlin; K Oberg; E T Janson; B Eriksson
Journal:  Med Oncol       Date:  2002       Impact factor: 3.064

6.  Glucagonoma and pseudoglucagonoma syndrome.

Authors:  Miguel Echenique-Elizondo; Ana Tuneu Valls; José L Elorza Orúe; Ignacio Martinez de Lizarduy; Javier Ibáñez Aguirre
Journal:  JOP       Date:  2004-07

7.  Prospective, randomized, multicenter trial on the antiproliferative effect of lanreotide, interferon alfa, and their combination for therapy of metastatic neuroendocrine gastroenteropancreatic tumors--the International Lanreotide and Interferon Alfa Study Group.

Authors:  Siegbert Faiss; Ulrich-Frank Pape; Michael Böhmig; Yvonne Dörffel; Ulrich Mansmann; Werner Golder; Ernst Otto Riecken; Bertram Wiedenmann
Journal:  J Clin Oncol       Date:  2003-07-15       Impact factor: 44.544

8.  The glucagonoma syndrome. Clinical and pathologic features in 21 patients.

Authors:  R A Wermers; V Fatourechi; A G Wynne; L K Kvols; R V Lloyd
Journal:  Medicine (Baltimore)       Date:  1996-03       Impact factor: 1.889

9.  Hyperglucagonaemia and necrolytic migratory erythema in cirrhosis--possible pseudoglucagonoma syndrome.

Authors:  J A Doyle; A L Schroeter; R S Rogers
Journal:  Br J Dermatol       Date:  1979-11       Impact factor: 9.302

10.  [Necrolytic migratory erythema in glucagonoma syndrome].

Authors:  I Stark; C H Mensing; C A Sander
Journal:  Hautarzt       Date:  2008-01       Impact factor: 0.751
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.